Future directions in research Dr Cameron concludes by previewing ongoing research comparing outcomes for patients on ixekizumab alone versus ixekizumab combined with GLP-1 receptor agonists
Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Observations from LVAD patients also suggest that while many experience normalization of LV chamber geometry, changes in the ECM and the ratio of LV wall thickness to LV wall radius may not return to normal 37
Its a chronic illness, just like high blood pressure, heart disease, diabetes, and it should be managed similar to these other chronic illnesses. The law speaks to the fact that obesity is no longer being treated like a character flaw or a lack of willpower, said Schauer, who is the director of the Metamor Metabolic Institute in Baton Rouge, a partnership between LSU's Pennington Biomedical Research Center and Our Lady of the Lake